(Q53563062)
Statements
Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates. (English)
Earnshaw SR
Graham CN
Ettinger B
Amonkar MM
Lynch NO
Middelhoven H
1 October 2007
23
10
2517-2529